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ABSTRACT: Bicyclo[1.1.1]pentanes (BCPs) have found application as bioisosteres of aromatic rings in drug development. 
However, catalytic construction of this motif with adjacent stereocenters in high enantioselectivity from readily available 
starting materials still constitutes a significant synthetic challenge. Herein, we report a direct stereoselective synthesis of α-
chiral allylic BCPs by 1,3-difunctionalization of [1.1.1]propellane with Grignard reagents and allyl carbonates using iridium 
catalysis. This mild protocol proceeds via initial organometallic addition to [1.1.1]propellane followed by asymmetric allylic 
substitution, providing the products in high enantioselectivities over a broad range of substrates. Further derivatization of 
the products demonstrates the applicability of this method to the preparation of structurally diverse libraries of chiral BCP 
derivatives. 
Structural modification of known biologically active 
molecules to improve their physicochemical properties is 
an attractive strategy in late-stage pharmaceutical evolu-
tion.1 Methods to achieve this include installing polar 
groups, removal of lipophilic functionality, and replace-
ment of suboptimal groups with suitable bioisosteres.2 
Bicyclo[1.1.1]pentanes (BCPs) have been shown to be priv-
ileged bioisosteres of aromatic rings due to their unique 
three-dimensional carbon framework, which can signifi-
cantly improve aqueous solubility, membrane permeability, 
and metabolic stability (Scheme 1a).3 In this regard, many 
efforts have been dedicated to the preparation of function-
alized BCPs.4 The most commonly employed approach is 
via addition reactions to readily available [1.1.1]propellane 
(1),5 which is a versatile strategy due to the facile cleavage 
of the inverted central σ-bond under both radical6 and ani-
onic pathways.7 In spite of the considerable advances in 
this area, there are limited methods that have been devel-
oped for the enantioselective construction of functional-
ized BCPs featuring α-stereogenic centers, and no reports 
that achieve this in a single step from 1 using asymmetric 
catalysis. This is largely a result of the high reactivity of 1, 
which is susceptible to rearrangement reactions in the 
presence of transition metal catalysts.8 To circumvent this 
issue, methods to access α-chiral BCP derivatives have re-
lied on multi-step syntheses, where 1 is first transformed 
to a functionalized BCP before installation of the stereo-
genic center. Furthermore, to obtain high stereoselectivi-
ties, this typically requires stoichiometric chiral reagents9 
or chiral auxiliaries (Scheme 1b).10 It is only very recently 
that the feasibility of asymmetric catalysis has been 
demonstrated, including copper-catalyzed hydroboration 
of alkenyl-BCPs or rhodium-catalyzed C–H functionaliza-
tion of mono-substituted BCPs with diazo compounds 
(Scheme 1b).9b,11 
To streamline the preparation of α-chiral BCPs, it 
would be advantageous to access these motifs using 
asymmetric catalysis in a direct multicomponent 1,3-
difunctionalization of [1.1.1]propellane. This would pro-
vide rapid access to diverse chiral BCPs, thus facilitating 
their application in medicinal chemistry. Previous work by 
the groups of Szeimies, Knochel and Gleason has shown 
that BCP-metal species, generated in situ from 1 and or-
ganometallic reagents, can react in palladium- and copper-
catalyzed cross couplings.7a–c,12 However, to date, cross 
couplings of these BCP-metal reagents have only been ap-
plied in the synthesis of achiral products. We recognised 
iridium-catalyzed asymmetric allylic substitution as a po-
tential route to α-chiral BCPs (Scheme 1c),13 as these cata-
 
 
lyst systems tolerate hard nucleophiles, including or-
ganozinc reagents,14,15 reminiscent of those formed upon 
addition of organometallic reagents to 1.7b Whilst chiral 
iridium catalysts have been successfully used in asymmet-
ric allylations of aryl14 and primary alkyl zinc reagents 
with allylic carbonates,15 we questioned whether the in-
creased steric hindrance of the tertiary BCP-species would  
Scheme 1. Bioactive BCPs and Stereoselective Ap-
proaches to α-Chiral BCPs 
 
be compatible with the bulky iridium π-allyl complexes 
and provide branched allylic products in high regio- and 
enantioselectivity, especially considering the lower selec-
tivities previously observed with secondary alkyl zinc rea-
gents.15a If such a process were possible, the use of 1-aryl 
allylic electrophiles (R2 = aryl, Scheme 1c) would provide 
rapid access to products that represent an interesting class 
of bioisosteres of 1,1-diaryl compounds, where one of the 
aryl rings is replaced with the three dimensional BCP. The 
chiral 1,1-diaryl motif is one of the most important phar-
macophores in medicinal chemistry, with applications in 
over 20 different major disease areas.16 We now report a 
direct and highly enantioselective iridium-catalyzed trans-
formation of [1.1.1]propellane into α‑chiral 1,3-
difunctionalized BCPs. 
To explore the feasibility of our hypothesis, we inves-
tigated the allylation of BCP-metal reagents with racemic 
Boc-protected allylic alcohol 2a (Table 1). The addition of 
2-tolylmagnesium bromide to [1.1.1]propellane (1) led to 
BCP-Grignard intermediate 3,7b,9b which was subsequently 
reacted with 2a at room temperature in toluene in the 
presence of 2 mol% [Ir(cod)Cl]2 and 8 mol% (S)-
phosphoramidite ligand L.15a The desired coupling reaction 
occurred to give allylic BCP product 4 in 61% yield and 12% 
ee with a 5:1 branched/linear ratio (entry 1). The moder-
ate regioselectivity led us to suspect that a non-catalyzed 
pathway was also operative.17 This was confirmed by the 
formation of 4 in 49% yield (B/L = 1:2) when the reaction 
was performing in the absence of the iridium catalyst (en-
try 2). On the other hand, only trace product was observed 
when ZnCl2 was added prior to 2a, presumably due to the 
formation of the less nucleophilic BCP-zinc species (entry 
3). Pleasingly, when the BCP-zinc species was generated 
prior to the addition of the iridium catalyst and 2a, 4 was 
formed in high yield and with excellent enantioselectivity 
(entry 4). We subsequently investigated different allyl 
electrophiles and found that acetate 2b reacted with simi-
lar efficiency to 2a, while allylic alcohol 2c failed to gener-
ate the desired product (entries 5 and 6). Evaluation of 
different solvents showed toluene to be optimal (entries 7-
9), and an iridium-to-ligand ratio of 1:2 was found to be 
essential for obtaining high yield (entry 10). Finally, lower-
ing the catalyst loading resulted in a marginal decrease in 
yield while still maintaining the excellent enantioselectivi-
ty (entry 11). 
Table 1. Optimization Studiesa 
 
Entry 




B/Lc % eed 
1 No ZnCl2 61b 5:1 12 
2 No ZnCl2, no Ir/L 49c 1:2 - 
3 No Ir/L <5 >20:1 - 
4 None 78 >20:1 99 
5 2b instead of 2a 74 >20:1 98 
6 2c instead of 2a <5 >20:1 - 
7 CH2Cl2 as solvent 55 >20:1 96 
8 THF as solvent 72 >20:1 92 
9 MeOAc as solvent 81 >20:1 94 
10 4 mol% L 34 >20:1 98 




a Reaction conditions: Allyl electrophile (0.40 mmol), 1 (3.2 
equiv), 2-tolylmagnesium bromide (1.6 equiv), ZnCl2 (2.0 equiv), 
[Ir(cod)Cl]2 (2.0 mol%), L (8.0 mol%), solvent (2 mL), r.t., 20 h. b 
Isolated yields. c B/L (branched/linear ratio) determined by 
GC/MS analysis. d Determined by HPLC analysis. 
Scheme 2. Substrate Scopea 
a Reaction conditions: 1 (3.2 equiv), 2-tolylmagnesium bromide (1.6 equiv), ZnCl2 (2.0 equiv), allyl electrophile (0.40 mmol), 
[Ir(cod)Cl]2 (2.0 mol%), (S)-L (8.0 mol%), toluene (2 mL), r.t., 20 h. Yields are of isolated products. The ee values were determined 
by HPLC analysis. b Ar1 = 2-tolyl. c 1 mmol scale. d Using (R)-L (8 mol%). e Ar2 = 2-naphthyl. f Yield determined after hydrobora-
tion/oxidation.  
 
Having identified optimal conditions, we assessed the 
scope of the reaction (Scheme 2). A series of 1-aryl allylic 
carbonates with various substituents on the aromatic ring 
provided the allylic BCP products 4–16 in high yields and 
excellent enantioselectivities. Various functionality was 
tolerated, including halides (6, 11, 13–14), trifluoromethyl 
(7), phenylsulfonyl (8), ester (9), and alkoxy groups (10). 
Substrates derived from nitrogen heterocycles, including 
quinolines (14–15) and pyridines (16) were also suitable, 
although a 3-pyridyl substrate, which possesses a sterically 
 
 
unhindered basic nitrogen atom, provided only a moderate 
yield of product 16 but still with excellent enantioselectivi-
ty. Although enantiocontrol was consistently high for the 
majority of substrates (98–99% ee), those with strong 
electron-withdrawing groups in the para-position of the 
aromatic ring (9), or those with ortho-substituents (13–14) 
gave slightly reduced enantioselectivities (87–89% ee). In 
addition to 1-aryl allylic carbonates, a 1,4-enyne (17) and a 
polysubstituted 1,4-diene derived from the natural prod-
uct (−)-perillaldehyde (18) also furnished the products in 
high yields and stereoselectivities. Interestingly, during the 
synthesis of perillaldehyde-derived product 18, we ob-
served low diastereocontrol when using the (S)-configured 
ligand (S)-L but high selectivity for the same diastereomer 
with (R)-L, which demonstrates a surprisingly high level of 
substrate-control considering the remoteness of the stere-
ocenters. Unfortunately, when a more sterically hindered 
diene substrate derived from (1R)-(−)-myrtenal was used, 
the linear regioisomer 19 was formed as the major prod-
uct in low yield. As commonly observed with related sys-
tems,15 the presence of an adjacent π-system and terminal 
olefin on the allyl substrate was found to be crucial for the 
substitution reaction, as the reactions failed for tert-butyl 
(1-cyclohexylallyl) carbonate and (E)-1-phenyl-3-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)allyl acetate. 
We next examined the generality of the reaction with 
respect to the Grignard reagent. Various functionalized 
aryl Grignards provided the corresponding chiral aryl-BCP 
derivatives (20-27) good yields and with excellent enanti-
oselectivities. Alkenyl Grignards were also found to be 
compatible for the ring-opening of 1, providing the bis-
alkene-functionalized BCP product 28 in 97% ee. In addi-
tion to C(sp2)-Grignard reagents, C(sp3)-Grignard reagents 
were also applicable in this [1.1.1]propellane derivatiza-
tion, providing alkyl-BCPs functionalized with allyl (29), 
primary alkyl (30), and cycloalkyl (31–32) groups. 
To demonstrate the potential application of our strat-
egy for the preparation of diverse libraries of chiral BCP 
derivatives, various transformations of the terminal alkene 
of the allyl-BCP products were performed (Scheme 3). Al-
cohol 33 was accessed in excellent yield by a hydrobora-
tion/oxidation sequence with 9-BBN, or iridium-catalyzed 
hydroboration with pinacolborane provided boronic ester 
34.18 Amine-substituted BCP derivative 35 was prepared 
by reductive ozonolysis and subsequent Mitsunobu-type 
nucleophilic substitution with phthalimide. Oxidation of 
the alkene with m-CPBA or OsO4 provided high yields of 
epoxide 36 and vicinal diol 37, respectively. Cyclopropana-
tion was readily accomplished with dimethyl diazomalo-
nate in the presence of a rhodium catalyst, affording cyclo-
propane 38 in 88% yield.19 Finally, alkenyl-BCP 4 was 
shown to undergo various radical-mediated transfor-
mations without erosion of enantioselectivity, including a 
photocatalyzed hydrofluoroalkylation and a copper-
catalyzed trifluoromethylazidation, which provided fluori-
nated BCP-derivatives 39 and 40 in high yields, respective-
ly.20,21 
To determine the absolute configuration of the α-
chiral BCP products formed using this iridium-catalyzed 
allylation, we compared the optical rotation to the report-
ed value for the previously synthesized phthalimide-
derivative 35.11 This allowed us to confirm that the prod-
ucts formed using (S)-L had an (R)-configuration, which is 
consistent with those previously described for Ir/L-
catalyzed reactions of allyl electrophiles with various nu-
cleophiles,13a including primary alkyl zinc reagents,15a and 
is indicative of a similar mechanistic pathway.22 It is note-
worthy that our new approach to α-chiral BCP derivatives 
allowed access to phthalimide 35 in 3 steps from 1 with 51% 
overall yield and 99% ee, whereas the previously reported 
synthesis required 6 steps and proceeded in 23% yield and 
90% ee. 
Scheme 3. Product Derivatizations 
 
Conditions: a 5 (Ar = 4-biphenyl), 9-BBN, THF, then H2O2, 
NaOH; b 4, HBpin, [Ir(cod)Cl]2, dppb, THF; c 6, O3, 
CH2Cl2/MeOH, NaBH4, then phthalimide, PPh3, DIAD, THF; d 4, 
m-CPBA, CH2Cl2; e 4, K2OsO4, K3Fe(CN)6, K2CO3, DABCO, 
tBuOH/H2O; f 4, dimethyl diazomalonate, Rh2(esp)2, CH2Cl2; g 
4, FSO2CF2CO2Me, Ir(ppy)3, NMP, blue LEDs; h 4, Togni reagent 
II, TMSN3, Cu(MeCN)4PF6, MeCN. 
 
In summary, we have developed a new strategy for 
the highly enantioselective construction of α-chiral BCPs in 
a single step from readily available [1.1.1]propellane. This 
was accomplished by a highly efficient iridium-catalyzed 
asymmetric allylic substitution of BCP-zinc intermediates, 
which are readily formed through the reaction of Grignard 
reagents, [1.1.1]propellane, and ZnCl2. Using this approach, 
we have synthesized an array of enantioenriched 1,3-
difunctionalized BCPs tethered with a terminal alkene, 
which provided a versatile synthetic handle for the prepa-
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